DADTF yields 100000.00% · MRK yields 2.81%● Live data
📍 DADTF pulled ahead of the other in Year 1
Combined, DADTF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DADTF + MRK for your $10,000?
DataDot Technology Limited, together with its subsidiaries, manufactures and distributes asset identification, management, protection, and authentication solutions in Asia, the Americas, Africa, Australia, and Europe. The company operates through three segments: DataDotDNA, DataTraceID, and DataDot-Vault. It offers DataDotDNA polymer and metallic microdots; asset registers, which are databases that record asset identification data and are accessible by law enforcement agencies and insurance investigators; security DataTraceID authentication solutions; and DataDot-VAULT asset protection products and services. The company also provides theft deterrence solutions, such as ToolMate that protects tools, as well as deters thieves using the microdot identification technology; and PartMate, which combines microdots with encoded serial numbers and a hidden tracer that can be viewed with a black-light. In addition, it offers authentication solutions for liability reduction, warranty claims, counterfeit detection, track and trace, grey market/diversion, supply chain management, enhanced packaging, retail loss prevention, credentials/ID cards, and document security. Further, the company offers DataDotDNA National Register, a law enforcement resource center that allows customers to verify the original owner of assets protected by DataDotDNA. Additionally, it operates as a re-seller of PadJack's range of network security products. The company sells its products to governments, police, insurance, and other companies within the automotive industry through a network of distributors. DataDot Technology Limited incorporated in 2000 and is based in Brookvale, Australia.
Full DADTF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.